Australia markets close in 1 hour 6 minutes

Corcept Therapeutics Incorporated (CORT)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
28.70+0.37 (+1.31%)
At close: 04:00PM EDT
28.71 +0.01 (+0.03%)
After hours: 07:58PM EDT
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Cash flows from operating activities
Net income
111,844
112,512
106,011
94,181
75,410
Depreciation & amortisation
3,126
3,067
2,237
2,171
236
Deferred income taxes
-229
4,346
14,089
16,877
14,067
Stock-based compensation
43,591
42,931
33,539
29,313
23,747
Change in working capital
14,380
-57
-5,357
-4,687
3,926
Accounts receivable
-4,978
-1,427
-6,270
-2,340
-2,288
Inventory
2,415
3,444
-3,514
-1,044
-7,779
Accounts payable
2,152
-3,597
3,161
-735
-389
Other working capital
177,362
167,423
150,732
135,029
115,367
Other non-cash items
5,005
5,093
1,451
-1,738
-1,721
Net cash provided by operating activities
177,717
167,892
151,970
136,117
115,665
Cash flows from investing activities
Investments in property, plant and equipment
-355
-469
-1,238
-1,088
-298
Purchases of investments
-278,028
-312,805
-420,114
-299,035
-233,124
Sales/maturities of investments
367,297
449,400
302,089
182,295
142,655
Net cash used for investing activities
88,914
136,126
-119,263
-117,828
-90,767
Cash flows from financing activities
Debt repayment
-
-
-
0
0
Common stock repurchased
-262,444
-295,985
-9,945
-30,975
-23,657
Other financing activities
-8,279
-22,835
-1,067
-6,089
-
Net cash used provided by (used for) financing activities
-257,150
-302,591
12,214
-28,645
-14,335
Net change in cash
9,481
1,427
44,921
-10,356
10,563
Cash at beginning of period
52,381
76,190
31,269
41,625
31,062
Cash at end of period
61,862
77,617
76,190
31,269
41,625
Free cash flow
Operating cash flow
177,717
167,892
151,970
136,117
115,665
Capital expenditure
-355
-469
-1,238
-1,088
-298
Free cash flow
177,362
167,423
150,732
135,029
115,367